Literature DB >> 6791651

Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase.

O Suzuki, Y Katsumata, M Oya.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791651

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

1.  The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.

Authors:  A M O'Carroll; C J Fowler; J P Phillips; I Tobbia; K F Tipton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-04       Impact factor: 3.000

2.  Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.

Authors:  Adam L Halberstadt
Journal:  Pharmacol Biochem Behav       Date:  2016-01-15       Impact factor: 3.533

3.  Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Ai-Ming Yu
Journal:  Drug Metab Dispos       Date:  2011-04-04       Impact factor: 3.922

Review 4.  Effect of Hallucinogens on Unconditioned Behavior.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2018

Review 5.  Indolealkylamines: biotransformations and potential drug-drug interactions.

Authors:  Ai-Ming Yu
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

6.  Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.

Authors:  Joaquim Soler; Matilde Elices; Alba Franquesa; Steven Barker; Pablo Friedlander; Amanda Feilding; Juan C Pascual; Jordi Riba
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

Review 7.  Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatric disorders.

Authors:  D D Mousseau
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

8.  The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222.

Authors:  M Strolin Benedetti; T Boucher; C J Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-08       Impact factor: 3.000

9.  Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.

Authors:  Adam L Halberstadt; Mahalah R Buell; Virginia L Masten; Victoria B Risbrough; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2008-07-08       Impact factor: 4.530

10.  Normetanephrine and metanephrine oxidized by both types of monoamine oxidase.

Authors:  O Suzuki; T Matsumoto
Journal:  Experientia       Date:  1985-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.